IART Integra LifeSciences Holdings C
$11.99▼ -0.91%
Healthcare
Other
After hours
$11.99▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.43M
Avg Volume (10D) 1.17M
Key Metrics & Fundamentals
Market Cap
$932.49M
P/E Ratio
70.5
Div Yield
0.00%
52W Range
8.70 - 20.49
% vs 50 MA
-20.63%
% vs 200 MA
-14.76%
RSI-14
34.5
MACD Histogram
-0.0700
Beta (1Y vs SPY)
1.74
Free Cash Flow
$10.50M
Gross Rev
$418.76M
Gross Profit
$219.74M
EBITDA
$65.87M
COGS
$199.02M
Operating Exp
$200.46M
Operating Income
$19.29M
EBIT
$19.29M
Pretax Income
$4.74M
Net Income
$4.48M
EPS (Diluted)
0.06
Price & Volume History
Loading chart…
Recent News
UBS Adjusts Integra LifeSciences Price Target to $14 From $19, Maintains Neutral Rating
MT Newswires · Oct 27, 2026 9:08 AM ET

3 value stocks we find risky
StockStory · Oct 26, 2026 4:30 PM ET

Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions
Simply Wall St. · Oct 24, 2026 7:16 AM ET
Truist Adjusts Price Target on Integra LifeSciences to $13 From $15, Maintains Hold Rating
MT Newswires · Oct 23, 2026 11:38 AM ET

IART Q3 deep dive: Cincinnati disruption and Tissue Reconstruction challenges weigh on outlook
StockStory · Oct 22, 2026 4:46 AM ET

Integra LifeSciences (IART) Stock Price Sinks As Q3 Earnings Revive Refinancing Worries
Simply Wall St. · Oct 22, 2026 3:17 AM ET

Why Integra LifeSciences (IART) stock is falling today
StockStory · Oct 21, 2026 5:26 PM ET

Integra: 3 Key Takeaways for Long-Term Investors
Motley Fool · Oct 21, 2026 2:11 PM ET

Integra (IART) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 21, 2026 1:17 PM ET

Integra LifeSciences Holdings Corporation Q3 2026 Earnings Call Summary
Moby · Oct 21, 2026 12:44 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IART's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.